FierceBiotech9d
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...
Pharmaceutical Technology16d
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and ...
pharmaphorum14d
Ono, Boehringer add to cancer pipelines with licensing deals
Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma ...
WTEN9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention.
BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to ...
GlobalData on MSN9d
Boehringer partners WHO Foundation to advance healthcare access
Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Pharmabiz13d
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...
Pharmabiz8d
Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...
Joplin Globe15d
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...
Ottumwa Courier9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...